Please provide your email address to receive an email when new articles are posted on . There is a need to look past dopaminergic therapy and target inflammation for disease modification. Chronic ...

The neurotransmitter dopamine influences the activity of a wide variety of brain areas. A deficiency of this substance can have drastic consequences: The death of dopamine-producing nerve cells in the ...

Researchers from Kumamoto University, Japan have found that a component derived from turmeric essential oil, aromatic turmerone (ar-turmerone), and its derivatives act directly on dopaminergic nerves ...

Loss of dopaminergic neurons in the substantia nigra and accumulation of α-synuclein (α-Syn) aggregates are the major hallmarks of Parkinson’s disease (PD).

Altered dopaminergic neurotransmission underlies a variety of neurological and neuropsychiatric diseases, including playing a central role in the neurodegenerative processes that lead to Parkinson’s ...

A diabetes drug called lixisenatide has produced the first strong clinical evidence that a small molecule can slow the actual progression of Parkinson’s disease, not simply mask its symptoms. In a ...